Association Between Angiotensin Blockade and Response to PD-1/L1 Inhibition in Metastatic Urothelial Carcinoma

Oncology

@sonpavde, of @DanaFarber_GU, discusses the effects of #angiotensin blockade on #PD-1/L1 inhibition in #metastatic #urothelialcarcinoma.

Therapeutic Effects of WST11 Vascular-Targeted Photodynamic Therapy

Urology

@lucasmnnogueira, of @sloan_kettering, discusses the #safety and #efficacy of WST11 vascular-targeted #photodynamic therapy.

Case Discussion: 49-Year-Old Male With UTUC

Oncology

@MattMossanen; @sonpavde; Steven L Chang, MD, MS; Michelle S. Hirsch, MD, PhD; and Mark A. Preston, MD, PhD, discuss a patient with #UTUC.

ASCO GU 2019: Updates on Treatment and Management of Bladder Cancer

Oncology

Updated Guidelines for Treatment of Non-Metastatic MBIC to be Presented at AUA Meeting

Bladder Cancer Content Hub

The AUA has teamed up with ASCO, ASTRO, and SUO to provide new guidelines for non-metastatic MBIC treatment.

Pelvic Radiotherapy Provides Long-Term Palliation In Patients With Bladder and Prostate Cancer

Bladder Cancer Content Hub

A recent study investigated utilizing palliative pelvic radiotherapy for metastatic bladder or prostate cancer patients.

Multiple Clinical Trials of Immunotherapies for Recurrent and Metastatic Cancers Are Reaching Maturation

Bladder Cancer Content Hub

There are currently a large number of ongoing trials examining immunotherapies for bladder, kidney, prostate, and renal cancers.

Accurate Staging of Bladder Cancer Proves Crucial for Improving Disease Treatment

Bladder Cancer Content Hub

Muscle-invasive bladder cancer (MIBC) is considered to be T2 stage due to tumor invasion into the muscle wall.

Super-Responders vs. Hyper-Progression with Immunotherapy

Bladder Cancer Content Hub

The trial revealed a linear correlation between higher tumor burden and anti-PD1 and anti-programmed death ligand (PD-L1) checkpoint inhibitors, explained as the immune system responding to reactivation.

Combination Therapy May Provide Synergies for Some Patients with Bladder Cancer

Bladder Cancer Content Hub

Multiple clinical trials are currently underway examining the possible synergistic effects of combining chemotherapy with immunotherapies for patients with bladder cancer and other metastases.